Total planned funding: $1,465,713,937
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $239,658,425 |
Tanzania | $186,826,372 |
Zambia | $154,774,996 |
Kenya | $142,813,370 |
Mozambique | $119,551,264 |
Ethiopia | $107,182,374 |
Uganda | $101,094,512 |
Côte d'Ivoire | $79,082,600 |
South Africa | $75,160,794 |
Rwanda | $60,071,886 |
Zimbabwe | $50,064,913 |
Vietnam | $29,424,335 |
Botswana | $18,811,799 |
Haiti | $15,785,993 |
Namibia | $13,467,903 |
Eswatini | $11,375,008 |
Malawi | $6,670,800 |
Guyana | $6,223,322 |
Democratic Republic of the Congo | $6,045,438 |
Burundi | $5,566,567 |
Central America Region | $5,276,552 |
Indonesia | $5,216,613 |
Ukraine | $4,650,000 |
Ghana | $3,587,508 |
Caribbean Region | $3,536,781 |
Lesotho | $2,530,000 |
Angola | $2,384,000 |
Russia | $1,850,000 |
India | $1,689,272 |
Dominican Republic | $1,650,000 |
South Sudan | $1,474,390 |
Cambodia | $1,000,000 |
China | $716,150 |
Cameroon | $500,000 |
Central Asia Region | $0 |
Organizational Types
Private Contractor | $1,465,713,937 |
Program Areas
Treatment | $700,068,659 |
Governance and Systems | $314,613,629 |
Care | $193,729,370 |
Prevention | $188,667,646 |
Testing | $62,374,430 |
Budget Codes
HTXD: Treatment: ARV Drugs | $554,758,955 |
OHSS: Health Systems Strengthening | $143,479,662 |
HTXS: Treatment: Adult Treatment | $127,602,805 |
HLAB: Laboratory Infrastructure | $126,700,971 |
HBHC: Care: Adult Care and Support | $99,172,271 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $75,030,408 |
HVCT: Testing: HIV Testing and Counseling | $62,374,430 |
HKID: Care: Orphans and Vulnerable Children | $56,906,704 |
HVSI: Strategic Information | $44,432,996 |
HVOP: Sexual Prevention: Other Sexual Prevention | $36,416,401 |
HVTB: Care: TB/HIV | $29,261,855 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $28,589,716 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $19,750,665 |
PDTX: Treatment: Pediatric Treatment | $17,706,899 |
HMIN: Biomedical Prevention: Injection Safety | $16,112,674 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,494,434 |
PDCS: Care: Pediatric Care and Support | $8,388,540 |
HMBL: Biomedical Prevention: Blood Safety | $4,273,348 |
Top Partner Programs
Chemonics International:
$119,735,153
View countries
Deloitte Consulting Limited:
$54,803,446
View countries